Literature DB >> 21194943

Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.

Alexandra Gaspar1, Joana Reis, André Fonseca, Nuno Milhazes, Dolores Viña, Eugenio Uriarte, Fernanda Borges.   

Abstract

Monoamine oxidase (MAO) is an enzyme, present in mammals in two isoforms MAO-A and MAO-B. These isoforms have a crucial role in neurotransmitters metabolism, representing an attractive drug target in the therapy of neurodegenerative diseases (MAO-B) and depression (MAO-A). In this context, our work has been focused on the discovery of new chemical entities (NCEs) for MAO inhibition, based on the development of chromone carboxamides. Chromone derivatives with a carboxamide function located in position 2- and 3- of the benzo-γ-pyrone core, (compounds 2-6 and 8-12) were synthesized, with moderate/good yields, by a one-pot condensation reaction using phosphonium salts as coupling reagents. The synthetic compounds were screened towards human MAO isoforms (hMAO) to evaluate their potency and selectivity. The chromone-3-carboxamides show high selectivity to hMAO-B, with compounds 9 and 12 displaying IC(50) values at nanomolar range. Copyright Â
© 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21194943     DOI: 10.1016/j.bmcl.2010.11.128

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase.

Authors:  Annah N Mpitimpiti; Jacobus P Petzer; Anél Petzer; Johannes H L Jordaan; Anna C U Lourens
Journal:  Mol Divers       Date:  2019-01-21       Impact factor: 2.943

2.  2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.

Authors:  Lesetja J Legoabe; Anél Petzer; Jacobus P Petzer
Journal:  Drug Des Devel Ther       Date:  2015-07-15       Impact factor: 4.162

3.  The crystal structures of four N-(4-halophen-yl)-4-oxo-4H-chromene-3-carboxamides.

Authors:  Ligia R Gomes; John Nicolson Low; Fernando Cagide; Fernanda Borges
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-01

4.  Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold.

Authors:  Maykel Cruz-Monteagudo; Fernanda Borges; M Natalia D S Cordeiro; Aliuska Morales Helguera; Eduardo Tejera; Cesar Paz-Y-Mino; Aminael Sanchez-Rodriguez; Yunier Perera-Sardina; Yunierkis Perez-Castillo
Journal:  Curr Neuropharmacol       Date:  2017-11-14       Impact factor: 7.363

Review 5.  Computer-aided Drug Design Applied to Parkinson Targets.

Authors:  Hamilton M Ishiki; Jose Maria Barbosa Filho; Marcelo S da Silva; Marcus T Scotti; Luciana Scotti
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

6.  Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.

Authors:  Irene Pachón-Angona; Bernard Refouvelet; Rudolf Andrýs; Helène Martin; Vincent Luzet; Isabel Iriepa; Ignacio Moraleda; Daniel Diez-Iriepa; María-Jesús Oset-Gasque; José Marco-Contelles; Kamil Musilek; Lhassane Ismaili
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 7.  From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease.

Authors:  Jazmín Alarcón-Espósito; Michael Mallea; Julio Rodríguez-Lavado
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.